BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 21942498)

  • 1. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
    Shiao YS; Chiu HH; Wu PH; Huang YF
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
    Alexander CM; Dabrowiak JC; Maye MM
    Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-capped nanoparticles designed for doxorubicin drug delivery.
    Alexander CM; Maye MM; Dabrowiak JC
    Chem Commun (Camb); 2011 Mar; 47(12):3418-20. PubMed ID: 21286626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen.
    Chen SJ; Huang CC; Chang HT
    Talanta; 2010 Apr; 81(1-2):493-8. PubMed ID: 20188952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
    Zhang X; Chibli H; Mielke R; Nadeau J
    Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.
    Qiao G; Zhuo L; Gao Y; Yu L; Li N; Tang B
    Chem Commun (Camb); 2011 Jul; 47(26):7458-60. PubMed ID: 21589964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells.
    Li R; Wu R; Zhao L; Wu M; Yang L; Zou H
    ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
    Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
    Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles.
    Wang X; Cai X; Hu J; Shao N; Wang F; Zhang Q; Xiao J; Cheng Y
    J Am Chem Soc; 2013 Jul; 135(26):9805-10. PubMed ID: 23789713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
    Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
    Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
    Ray L; Kumar P; Gupta KC
    Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.